European Neuromuscular Centre consensus statement on anaesthesia in patients with neuromuscular disorders.

Humans Child Neuromuscular Diseases Muscular Diseases Anesthesia Anesthetics Neuromuscular Junction Diseases
anaesthesia malignant hyperthermia myopathy neuromuscular disorders perioperative care

Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
12 2022
Historique:
revised: 05 07 2022
received: 01 06 2022
accepted: 11 08 2022
pubmed: 17 8 2022
medline: 4 11 2022
entrez: 16 8 2022
Statut: ppublish

Résumé

Patients with neuromuscular conditions are at increased risk of suffering perioperative complications related to anaesthesia. There is currently little specific anaesthetic guidance concerning these patients. Here, we present the European Neuromuscular Centre (ENMC) consensus statement on anaesthesia in patients with neuromuscular disorders as formulated during the 259th ENMC Workshop on Anaesthesia in Neuromuscular Disorders. International experts in the field of (paediatric) anaesthesia, neurology, and genetics were invited to participate in the ENMC workshop. A literature search was conducted in PubMed and Embase, the main findings of which were disseminated to the participants and presented during the workshop. Depending on specific expertise, participants presented the existing evidence and their expert opinion concerning anaesthetic management in six specific groups of myopathies and neuromuscular junction disorders. The consensus statement was prepared according to the AGREE II (Appraisal of Guidelines for Research & Evaluation) reporting checklist. The level of evidence has been adapted according to the SIGN (Scottish Intercollegiate Guidelines Network) grading system. The final consensus statement was subjected to a modified Delphi process. A set of general recommendations valid for the anaesthetic management of patients with neuromuscular disorders in general have been formulated. Specific recommendations were formulated for (i) neuromuscular junction disorders, (ii) muscle channelopathies (nondystrophic myotonia and periodic paralysis), (iii) myotonic dystrophy (types 1 and 2), (iv) muscular dystrophies, (v) congenital myopathies and congenital dystrophies, and (vi) mitochondrial and metabolic myopathies. This ENMC consensus statement summarizes the most important considerations for planning and performing anaesthesia in patients with neuromuscular disorders.

Sections du résumé

BACKGROUND AND PURPOSE
Patients with neuromuscular conditions are at increased risk of suffering perioperative complications related to anaesthesia. There is currently little specific anaesthetic guidance concerning these patients. Here, we present the European Neuromuscular Centre (ENMC) consensus statement on anaesthesia in patients with neuromuscular disorders as formulated during the 259th ENMC Workshop on Anaesthesia in Neuromuscular Disorders.
METHODS
International experts in the field of (paediatric) anaesthesia, neurology, and genetics were invited to participate in the ENMC workshop. A literature search was conducted in PubMed and Embase, the main findings of which were disseminated to the participants and presented during the workshop. Depending on specific expertise, participants presented the existing evidence and their expert opinion concerning anaesthetic management in six specific groups of myopathies and neuromuscular junction disorders. The consensus statement was prepared according to the AGREE II (Appraisal of Guidelines for Research & Evaluation) reporting checklist. The level of evidence has been adapted according to the SIGN (Scottish Intercollegiate Guidelines Network) grading system. The final consensus statement was subjected to a modified Delphi process.
RESULTS
A set of general recommendations valid for the anaesthetic management of patients with neuromuscular disorders in general have been formulated. Specific recommendations were formulated for (i) neuromuscular junction disorders, (ii) muscle channelopathies (nondystrophic myotonia and periodic paralysis), (iii) myotonic dystrophy (types 1 and 2), (iv) muscular dystrophies, (v) congenital myopathies and congenital dystrophies, and (vi) mitochondrial and metabolic myopathies.
CONCLUSIONS
This ENMC consensus statement summarizes the most important considerations for planning and performing anaesthesia in patients with neuromuscular disorders.

Identifiants

DOI: 10.1111/ene.15526 PMID: 35971866 PMC: PMC9826444
pubmed: 35971866
doi: 10.1111/ene.15526
pmc: PMC9826444
doi:

Substances chimiques

Anesthetics 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3486-3507

Informations de copyright

© 2022 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.

Références

Neuromuscul Disord. 2018 Feb;28(2):103-115
pubmed: 29290580
Anesth Analg. 2005 Feb;100(2):393-397
pubmed: 15673864
Br J Anaesth. 2019 Apr;122(4):448-459
pubmed: 30857601
Neurology. 2013 Aug 20;81(8):770-1
pubmed: 23873972
Anesthesiology. 2002 Nov;97(5):1067-74
pubmed: 12411788
Neurology. 2003 Oct 14;61(7):997-1000
pubmed: 14557579
Muscle Nerve. 2004 Jul;30(1):114-7
pubmed: 15221887
Arthroscopy. 2018 Feb;34(2):349-351
pubmed: 29413182
Muscle Nerve. 2020 Oct;62(4):430-444
pubmed: 32270509
J Paediatr Child Health. 2015 Aug;51(8):759-64
pubmed: 25752877
Neuromuscul Disord. 2005 Aug;15(8):532-40
pubmed: 16009551
Hum Mutat. 2012 Jun;33(6):981-8
pubmed: 22473935
Anaesthesia. 2020 May;75(5):654-663
pubmed: 32017012
BMC Anesthesiol. 2019 Nov 19;19(1):213
pubmed: 31744470
BMC Pediatr. 2020 Feb 6;20(1):57
pubmed: 32028919
Case Rep Anesthesiol. 2019 Mar 20;2019:4282305
pubmed: 31016049
Paediatr Anaesth. 2006 Dec;16(12):1293-4
pubmed: 17121566
Neurology. 2018 Jan 30;90(5):e412-e418
pubmed: 29298851
Am J Med Genet A. 2008 Jul 15;146A(14):1832-41
pubmed: 18553514
Lancet. 2019 Nov 30;394(10213):2025-2038
pubmed: 31789220
Br J Anaesth. 2010 Apr;104(4):397-400
pubmed: 20228183
Acta Myol. 2013 Oct;32(2):100-5
pubmed: 24399867
Continuum (Minneap Minn). 2019 Dec;25(6):1767-1784
pubmed: 31794470
Clin Pediatr (Phila). 1997 Jan;36(1):9-16
pubmed: 9007342
J Am Coll Cardiol. 2020 Apr 21;75(15):1772-1784
pubmed: 32299589
Hum Mutat. 2016 Nov;37(11):1231-1241
pubmed: 27586648
Can J Anaesth. 2003 Jun-Jul;50(6):547-52
pubmed: 12826544
Ann Neurol. 2011 Oct;70(4):662-5
pubmed: 22028225
Mol Med Rep. 2015 Oct;12(4):6267-74
pubmed: 26252573
Neuropediatrics. 2017 Aug;48(4):247-261
pubmed: 28669131
Eur J Anaesthesiol. 2012 Oct;29(10):489-94
pubmed: 22801582
Mol Genet Metab. 2014 Jun;112(2):139-42
pubmed: 24780638
J Child Neurol. 2017 Jun;32(7):663-670
pubmed: 28393671
Nat Rev Neurol. 2018 Mar;14(3):151-167
pubmed: 29391587
Anesthesiology. 2001 Mar;94(3):523-9
pubmed: 11374616
Pract Neurol. 2020 Oct 27;:
pubmed: 33109742
J Neuromuscul Dis. 2020;7(4):367-393
pubmed: 32773394
Orphanet J Rare Dis. 2019 Feb 26;14(1):57
pubmed: 30808424
CMAJ. 2010 Dec 14;182(18):E839-42
pubmed: 20603348
J Pediatr. 1999 Feb;134(2):206-14
pubmed: 9931531
Eur J Anaesthesiol. 2015 Oct;32(10):672-80
pubmed: 26086278
Br J Anaesth. 2015 Oct;115(4):531-9
pubmed: 26188342
Case Rep Anesthesiol. 2014;2014:680568
pubmed: 24715988
Anesth Analg. 2009 Oct;109(4):1043-8
pubmed: 19762730
Paediatr Anaesth. 2003 Feb;13(2):94-102
pubmed: 12562480
Sci Rep. 2021 Jan 11;11(1):8
pubmed: 33431966
Neurotherapeutics. 2018 Oct;15(4):943-953
pubmed: 30406383
Anaesthesia. 2012 Jun;67(6):612-7
pubmed: 22376088
Paediatr Anaesth. 2013 Sep;23(9):777-84
pubmed: 23869433
Life (Basel). 2020 Apr 17;10(4):
pubmed: 32316520
Neurol Clin. 2020 Aug;38(3):481-491
pubmed: 32703462
J Cardiothorac Vasc Anesth. 2019 Sep;33(9):2537-2545
pubmed: 30219643
Curr Opin Anaesthesiol. 2017 Jun;30(3):435-440
pubmed: 28448298
Mitochondrion. 2011 May;11(3):413-20
pubmed: 21167962
Neuromuscul Disord. 2011 Jun;21(6):420-7
pubmed: 21514828
J Clin Invest. 2016 Jan;126(1):239-53
pubmed: 26642364
Br J Anaesth. 2011 Mar;106(3):352-8
pubmed: 21258074
Neurology. 2017 Sep 26;89(13):1348-1354
pubmed: 28855409
Eur J Neurol. 2010 Jun 1;17(6):842-5
pubmed: 20100232
Anesth Analg. 2020 Feb;130(2):367-373
pubmed: 31124838
Neuromuscul Disord. 2020 Jul;30(7):539-545
pubmed: 32622512
Br J Anaesth. 2021 Jan;126(1):120-130
pubmed: 33131754
Anesth Analg. 2020 Dec;131(6):1872-1882
pubmed: 32769381
Paediatr Anaesth. 2013 Sep;23(9):855-64
pubmed: 23919455
Can J Anaesth. 2010 Mar;57(3):248-55
pubmed: 20077169
Curr Opin Neurol. 1996 Dec;9(6):477-85
pubmed: 9007409
J Anesth. 2015 Oct;29(5):794-7
pubmed: 25796520
Expert Rev Neurother. 2020 Dec;20(12):1287-1298
pubmed: 32941087
Acta Myol. 2020 Mar 01;39(1):2-12
pubmed: 32607473
Neurology. 1997 Dec;49(6):1646-50
pubmed: 9409361
PLoS Curr. 2015 Aug 07;7:
pubmed: 26331093
Can J Anaesth. 2022 Jun;69(6):756-773
pubmed: 35322378
Mitochondrion. 2016 Jan;26:26-32
pubmed: 26602285
Eur J Neurol. 2022 Dec;29(12):3486-3507
pubmed: 35971866
Anaesth Intensive Care. 2001 Feb;29(1):34-7
pubmed: 11261908
Neurol Clin. 2014 Aug;32(3):705-19, viii
pubmed: 25037086
Neuromuscul Disord. 2022 Jan;32(1):86-97
pubmed: 34916120
Br J Anaesth. 1993 Apr;70(4):397-401
pubmed: 8499197
Br J Anaesth. 2008 Apr;100(4):436-41
pubmed: 18285393
Continuum (Minneap Minn). 2019 Dec;25(6):1732-1766
pubmed: 31794469
J Child Neurol. 2014 Aug;29(8):NP40-6
pubmed: 24026895
Eur J Anaesthesiol. 2017 Oct;34(10):641-649
pubmed: 28719515
Br J Anaesth. 2018 Oct;121(4):944-952
pubmed: 30236257
Acta Anaesthesiol Scand. 2012 Apr;56(4):520-5
pubmed: 22260353
Anesthesiology. 2022 Jun 1;136(6):940-953
pubmed: 35285867
Anesthesiology. 2005 May;102(5):915-9
pubmed: 15851877
Anesthesiology. 1991 May;74(5):815-9
pubmed: 1673591
Drugs Context. 2019 Jul 04;8:212588
pubmed: 31391854
Neurol Genet. 2017 Mar 21;3(2):e140
pubmed: 28357410
Paediatr Anaesth. 2009 Aug;19(8):740-7
pubmed: 19624361
Paediatr Anaesth. 2013 Sep;23(9):824-33
pubmed: 23802937
Br J Anaesth. 2014 Jul;113(1):12-22
pubmed: 24893784
Acta Anaesthesiol Scand. 2005 Sep;49(8):1077-83
pubmed: 16095447
Neurotherapeutics. 2018 Oct;15(4):954-965
pubmed: 30341599
Heart Vessels. 2018 Dec;33(12):1576-1583
pubmed: 29766268
Paediatr Anaesth. 2006 Aug;16(8):840-5
pubmed: 16884467
Clin Genet. 2019 Aug;96(2):126-133
pubmed: 30919934
Paediatr Anaesth. 2013 Sep;23(9):794-803
pubmed: 23384336
Genet Med. 2021 Jul;23(7):1288-1295
pubmed: 33767344
Int J Physiol Pathophysiol Pharmacol. 2015 Dec 25;7(4):172-7
pubmed: 27073593
Int Heart J. 2019 Jan 25;60(1):12-18
pubmed: 30518714
Acute Med Surg. 2019 Dec 04;7(1):e473
pubmed: 31988785
J Inherit Metab Dis. 2020 Jul;43(4):800-818
pubmed: 32030781

Auteurs

Luuk R van den Bersselaar (LR)

Malignant Hyperthermia Investigation Unit, Department of Anaesthesiology, Canisius Wilhelmina Hospital Nijmegen, Nijmegen, The Netherlands.
Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands.
ORCID: 0000-0001-7735-3267

Luc Heytens (L)

Malignant Hyperthermia Research Unit, Departments of Anaesthesiology and Neurology, University Hospital Antwerp, University of Antwerp and Born Bunge Institute, Antwerp, Belgium.

Helga C A Silva (HCA)

Malignant Hyperthermia Unit, Department of Surgery, Discipline of Anaesthesia, Pain, and Intensive Care, São Paulo Federal University, São Paulo, Brazil.

Jens Reimann (J)

Department of Neurology, University of Bonn Medical Centre, Bonn, Germany.
ORCID: 0000-0003-3349-6877

Giorgio Tasca (G)

UOC of Neurology, A. Gemelli University Polyclinic Foundation, Scientific Institute for Research and Health Care, Rome, Italy.
ORCID: 0000-0003-0849-9144

Óscar Díaz-Cambronero (Ó)

Malignant Hyperthermia Unit, Department of Anaesthesiology, Perioperative Medicine Research Group, La Fe University and Polytechnic Hospital, Valencia, Spain.

Nicoline Løkken (N)

Copenhagen Neuromuscular Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Anna Hellblom (A)

Department of Intensive and Perioperative Care, Skåne University Hospital Lund, Lund, Sweden.

Philip M Hopkins (PM)

Leeds Institute of Medical Research at St James's, University of Leeds and Malignant Hyperthermia Investigation Unit, St James's University Hospital, Leeds, UK.

Henrik Rueffert (H)

Schkeuditz Helios Clinic, Malignant Hyperthermia Investigation Unit, Department of Anaesthesiology, Intensive Care, Pain Therapy, University Hospital Leipzig, Leipzig, Germany.

Börge Bastian (B)

Schkeuditz Helios Clinic, Malignant Hyperthermia Investigation Unit, Department of Anaesthesiology, Intensive Care, Pain Therapy, University Hospital Leipzig, Leipzig, Germany.

Juan Jesus Vilchez (JJ)

Neuromuscular Centre, La Fe Hospital UIP and ERN EURO-NMD, Neuromuscular Research Group at La Fe IIS and CIBERER, Valencia, Spain.
ORCID: 0000-0002-0532-2872

Robyn Gillies (R)

Malignant Hyperthermia Diagnostic Unit, Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Parkville, Victoria, Australia.

Stephan Johannsen (S)

Department of Anaesthesiology, Intensive Care, Emergency, and Pain Medicine, Centre for Malignant Hyperthermia, University Hospital Würzburg, Würzburg, Germany.

Francis Veyckemans (F)

Paediatric Anaesthesia Clinic, Jeanne de Flandre Hospital, Lille University Hospital Centre, Lille, France.

Tino Muenster (T)

Department of Anaesthesia and Intensive Care Medicine, Hospital of the Order of St John of God, Regensburg, Germany.

Andrea Klein (A)

Department of Paediatric Neurology, University Children's Hospital UKBB, Basel, Switzerland.
Division of Neuropaediatrics, Development, and Rehabilitation, Department of Paediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Ron Litman (R)

Department of Anaesthesiology and Critical Care, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Heinz Jungbluth (H)

Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's and St Thomas' Hospital National Health Service Foundation Trust, London, UK.
Randall Centre for Cell and Molecular Biophysics, Muscle Signalling Section, Faculty of Life Sciences and Medicine, King's College London, London, UK.
ORCID: 0000-0002-7159-3427

Sheila Riazi (S)

Malignant Hyperthermia Investigation Unit, Department of Anaesthesiology and Pain Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada.

Nicol C Voermans (NC)

Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands.

Marc M J Snoeck (MMJ)

Malignant Hyperthermia Investigation Unit, Department of Anaesthesiology, Canisius Wilhelmina Hospital Nijmegen, Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › European Neuromuscular Centre consensus...
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › European Neuromuscular Centre consensus...
questionsmedicales.fr › Maladies du système nerveux › Maladies neuromusculaires › European Neuromuscular Centre consensus...
questionsmedicales.fr › Maladies du système nerveux › Maladies neuromusculaires › Maladies musculaires › European Neuromuscular Centre consensus...
questionsmedicales.fr › Anesthésie et analgésie › Anesthésie › European Neuromuscular Centre consensus...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents du système nerveux central › Dépresseurs du système nerveux central › Anesthésiques › European Neuromuscular Centre consensus...
questionsmedicales.fr › Maladies du système nerveux › Maladies neuromusculaires › Maladies de la jonction neuromusculaire › European Neuromuscular Centre consensus...